biodyne (314930) has 18 disclosed insider purchases and 1 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩3.9B ($2.7M) in reported transaction value. The earliest filing StockDrifts holds for biodyne is dated 2024-02-28; the most recent is 2026-07-10. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +0.23%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-07-10 | BUY | Market Buy | 양근호 Yang Geun-ho | Internal director | 2.0K | ₩8,580 | -2.6% | ₩17M ($12K) |
| 2026-07-09 | BUY | Market Buy | 양근호 Yang Geun-ho | Internal director | 1.0K | ₩8,580 | -2.6% | ₩9M ($6K) |
| 2026-07-03 | BUY | Market Buy | 임욱빈 Wookbin Lim | CEO | 19.6K | ₩9,480 | -9.5% | ₩186M ($129K) |
| 2026-06-04 | BUY | Market Buy | 임욱빈 Wookbin Lim | CEO | 10.0K | ₩10,020 | -2.6% | ₩101M ($70K) |
| 2026-06-02 | BUY | Market Buy | 임욱빈 Wookbin Lim | CEO | 13.0K | ₩9,710 | +0.5% | ₩126M ($88K) |
| 2026-06-01 | BUY | Market Buy | 임욱빈 Wookbin Lim | CEO | 14.8K | ₩9,710 | +0.5% | ₩143M ($100K) |
| 2026-05-29 | BUY | Market Buy | 임욱빈 Wookbin Lim | CEO | 11.8K | ₩10,000 | -2.4% | ₩118M ($82K) |
| 2026-05-28 | BUY | Market Buy | 임욱빈 Wookbin Lim | CEO | 13.0K | ₩10,480 | -6.9% | ₩136M ($95K) |
| 2026-05-27 | BUY | Market Buy | 임욱빈 Wookbin Lim | CEO | 14.9K | ₩10,320 | -5.4% | ₩154M ($107K) |
| 2025-11-26 | BUY | Market Buy | 양근호 Yang Geun-ho | Internal director | 1.4K | ₩13,290 | +5.7% | ₩19M ($13K) |
| 2025-11-24 | BUY | Market Buy | 양근호 Yang Geun-ho | Internal director | 650 | ₩13,350 | +5.2% | ₩9M ($6K) |
| 2025-11-22 | BUY | Market Buy | 양근호 Yang Geun-ho | Internal director | 177 | ₩13,350 | +5.2% | ₩2M ($2K) |
| 2025-11-21 | BUY | Market Buy | 양근호 Yang Geun-ho | Internal director | 923 | ₩13,810 | +1.7% | ₩13M ($9K) |
| 2025-11-20 | BUY | Market Buy | 양근호 Yang Geun-ho | Internal director | 2.6K | ₩13,770 | +2.0% | ₩36M ($25K) |
| 2025-11-20 | BUY | Market Buy | 고유라 Go Yoo-ra | Internal director | 1.0K | ₩13,770 | +2.0% | ₩14M ($10K) |
| 2025-08-08 | SELL | 시간외매매 | 임욱빈 Wookbin Lim | CEO | -1.2M | ₩15,880 | +11.5% | ₩18.4B ($12.8M) |
| 2024-09-10 | BUY | Market Buy | 고유라 Go Yoo-ra | Internal director | 660 | ₩13,330 | +5.4% | ₩9M ($6K) |
| 2024-09-09 | BUY | Market Buy | 고유라 Go Yoo-ra | Internal director | 340 | ₩13,490 | +4.2% | ₩5M ($3K) |
| 2024-09-09 | BUY | Market Buy | 양근호 Yang Geun-ho | Internal director | 1.0K | ₩13,490 | +4.2% | ₩13M ($9K) |
| 2024-03-26 | BUY | 신규보고 | 고유라 Go Yoo-ra | Internal director | 1.9K | ₩9,310 | +50.9% | ₩17M ($12K) |
| 2024-03-26 | BUY | 신규보고 | 양근호 Yang Geun-ho | Internal director | 8.2K | ₩9,310 | +50.9% | ₩76M ($53K) |
| 2024-02-29 | BUY | 무상신주취득 | 조우석 Jo Woo-seok | CL | 168.8K | ₩11,890 | +18.2% | ₩2.0B ($1.4M) |
| 2024-02-29 | BUY | 무상신주취득 | 임욱빈 Wookbin Lim | CEO | 10.7M | ₩11,890 | +18.2% | ₩127.3B ($88.4M) |
| 2024-02-28 | SELL | Market Sell | 임욱빈 Wookbin Lim | CEO | -200.3K | ₩13,980 | -0.5% | ₩2.8B ($1.9M) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for biodyne. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.